MICHELLE SHIPPERT: Open Payments
NPI 1558546747 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,834 in 111 payments from 14 companies in 2025. Trend: 2023 $1,873 · 2024 $2,082 · 2025 $1,834
Food & beverage: $1,834
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 33 | $399 |
| Otsuka America Pharmaceutical, Inc. | 17 | $359 |
| ABBVIE INC. | 15 | $189 |
| E.R. Squibb & Sons, L.L.C. | 12 | $148 |
| Lundbeck LLC | 8 | $141 |
| Lilly USA, LLC | 2 | $136 |
| Alkermes, Inc. | 5 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $88 |
| Neurocrine BioSciences, Inc. | 5 | $81 |
| Janssen Pharmaceuticals, Inc | 4 | $79 |
Products named: CAPLYTA, REXULTI, ABILIFY MAINTENA, VRAYLAR, COBENFY, ZEPBOUND, TRINTELLIX, INGREZZA.
Industry payments across PA — which companies pay providers there.
